Key Dates

Related Announcements

RFA-NS-19-043 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)

RFA-NS-19-044 - Notice of Removal of Matching Requirements for RFA-NS-18-041 “Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)”

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

National Eye Institute (NEI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Center for Complementary and Integrative Health (NCCIH)

Purpose

The purpose of this Notice is to inform the extramural community that as a result of disruptions caused by the COVID-19 pandemic, the BRAIN Initiative will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of an application to the BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) through the February/March 2021 due dates.

Implementation

The two-receipt cycle extension in eligibility under this Notice applies only to applicants for a K99/R00 award under one of the BRAIN Initiative Diversity K99/R00 announcements (RFA-NS-19-043 or RFA-NS-19-044). For eligible applicants submitting new or resubmission applications, the two-receipt cycle extension will be automatically accepted by the NIH; no additional documentation is required.

To aid potential applicants in determining whether they are eligible for the extension, the following examples are provided:

Example 1:For individuals whose eligibility ended with the June/July 2020 due dates, the temporary extension would allow them to apply for the K99/R00 until February/March 2021.

Example 2:For individuals whose eligibility would normally end with October/November 2020 due dates, the temporary extension would allow them to apply in February/March 2021 or June/July 2021.

Example 3:For individuals whose eligibility would normally end with February/March 2021 due dates, the temporary extension would allow them to apply in June/July 2021 or October/November 2021.

This policy may be subject to future updates.

Prospective K99 applicants who wish to receive non-COVID-related extensions (such as those for childbirth, adoption, family leave, etc.) must continue to provide relevant documentation.

All other aspects of these FOAs remain unchanged. Prospective applicants strongly encouraged to consult with NIH scientific/research staff when planning an application, for guidance on program scope and appropriateness of the proposed research and training for potential funding in response to these FOAs.

Inquiries

Please direct all inquiries to:

Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email:[email protected]